5Piecha G,Adamczak M, Ritz E. Dyslipidemia in chronic kidney disease: pathogenesis and intervention [J ]. Pol Arch Med Wewn,2009,119(7 8) :487--492.
6Chmielewski M,Rutkowski B. Mechanisms of dyslipidemia in chronic kidney disease[J]. Am J Physiol Renal Physiol, 2009, 297 .- F835.
7Attman PO,Samuelsson O. Dyslipidemia of kidney diseas[J]. Curt Opin Lipidol,2009,20:293 -299.
8R udn XZ,Chen Y, Powis SH, et al. Inflammation causes statin resistance: a potential mechanism for ineffectiveness of statin therapy in patients with chronic inflammation abstract [ J]. J Am Soc Nephrol, 2007,18 .- 91A.
9Tonelli M, Isles C,Craven T, et al. Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease[J]. Circulation, 2005,112 ; 171.
10Shepherd J, Kastelein J J, Bittner V, et al. Intensive lipid lower- ing with atorvastatin in patients with coronary heart disease and chronic kidney disease [J]. J Am Coll Cardiol, 2008, 51 ..1 448.
